The role of growth hormone in neural development

Hormone Research

Volumn 64, Issue SUPPL. 3, 2005, Pages 66-72

  Scheepens, Arjan ^a   Möderscheim, Tanja A E ^a   Gluckman, Peter D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Brain; Development; Growth hormone; Growth hormone receptor

Indexed keywords

GLUCOCORTICOID; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C;

AUTOCRINE EFFECT; BRAIN DEVELOPMENT; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; HORMONAL REGULATION; HORMONE TRANSPORT; HUMAN; NEUROENDOCRINOLOGY; NONHUMAN; ONTOGENY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; AUTOCRINE COMMUNICATION; BRAIN; BRAIN INJURIES; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; ORGANOGENESIS; PARACRINE COMMUNICATION; RECEPTORS, SOMATOTROPIN;

EID: 31544443260     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089320     Document Type: Conference Paper

References (84)

1. Baumann G: Growth hormone binding protein 2001. J Pediatr Endocrinol Metab 2001;14:355-375.
2. Burton KA, Kabigting EB, Clifton DK, Steiner RA: Growth hormone receptor messenger ribonucleic acid distribution in the adult male rat brain and its colocalization in hypothalamic somatostatin neurons. Endocrinology 1992;131:958-963.
3. Lobie PE, Garcia-aragon J, Lincoln DT, Barnard R, Wilcox JN, Waters MJ: Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Brain Des Dev Brain Res 1993;74:225-233.
4. Harvey S, Lavelin I, Pines M: Growth hormone (GH) action in the brain: neural expression of a GH-response gene. J Mol Neurosci 2002;18:89-95.
5. Turnley AM, Faux CH, Rietze RL, Coonan JR, Bartlett PF: Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling. Nat Neurosci 2002;5:1155-1162.
6. Garofalo RS, Rosen OM: Insulin and insulin-like growth factor 1 (IGF-1) receptors during central nervous system development: expression of two immunologically distinct IGF-1 receptor beta subunits. Mol Cell Biol 1989;9:2806-2817.
7. Bondy CA, Werner H, Roberts CT Jr, LeRoith D: Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol Endocrinol 1990;4:1386-1398.
8. Bartlett WP, Li XS, Williams M, Benkovic S: Localization of insulin-like growth factor-1 mRNA in murine central nervous system during postnatal development. Dev Biol 1991;147:239-250.
9. Sernia C, Wyse B: Growth hormone (GH) regulates brain angiotensinogen. International Congress of Endocrinology, June 1996, San Francisco, Calif., pp 1-571.
10. Chen L, Lund PK, Burgess SB, Rudisch BE, Mcilwain DL: Growth hormone, insulin-like growth factor I and motoneuron size. J Neurobiol 1997;32:202-212.
11. Scheepens A, Sirimanne ES, Breier BH, Clark RG, Gluckman PD, Williams CE: Growth hormone as a neuronal rescue factor during recovery from CNS injury. Neuroscience 2001;104:677-687.
12. Gossard F, Dihl F, Pelletier G, Dubois PM, Morel G: In situ hybridization to rat brain and pituitary gland of growth hormone cDNA. Neurosci Lett 1987;79:251-256.
13. Hojvat S, Emanuele N, Baker G, Connick E, Kirsteins L, Lawrence AM: Growth hormone (GH), thyroid-stimulating hormone (TSH), and luteinizing hormone (LH)-like peptides in the rodent brain: non-parallel ontogenetic development with pituitary counterparts. Brain Res 1982;4:427-434.
14. Rosenfeld RG, Bengtsson BA: Effects of growth hormone and insulin-like growth factors on the central nervous system. Acta Paediatr Suppl 1994;406:89-91.
15. Han VK: Is the central nervous system a target for growth hormone and insulin-like growth factors? Acta Paediatr Suppl 1995;411:3-8.
16. Yoshizato H, Fujikawa T, Soya H, Tanaka M, Nakashima K: The growth hormone (GH) gene is expressed in the lateral hypothalamus: enhancement by GH-releasing hormone and repression by restraint stress. Endocrinology 1998;139:2545-2551.
17. Donahue CP, Jensen RV, Ochiishi T, Eisenstein I, Zhao M, Shors T, Kosik KS: Transcriptional profiling reveals regulated genes in the hippocampus during memory formation. Hippocampus 2002;12:821-833.
18. Sun LY, Al-Regaiey K, Masternak MM, Wang J, Bartke A: Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice. Neurobiol Ageing 2005;26:929-937.
19. Sun LY, Evans MS, Hsieh J, Panici J, Bartke A: Increased neurogenesis in dentate gyrus of long-lived Ames dwarf mice. Endocrinology 2005;146:1138-1144.
20. Prickaerts J, Koopmans G, Blokland A, Scheepens A: Learning and adult neurogenesis: survival with or without proliferation? Neurobiol Learn Mem 2004;81:1-11.
21. Ajo R, Cacicedo L, Navarro C, Sanchez-Franco F: Growth hormone action on proliferation and differentiation of cerebral cortical cells from fetal rat. Endocrinology 2003;144:1086-1097.
22. Jeay S, Sonenshein GE, Kelly PA, Postel-Vinay MC, Baixeras E: Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase. Endocrinology 2001;142:147-156.
23. Frago LM, Paneda C, Dickson SL, Hewson AK, Argente J, Chowen JA: Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology 2002;143:4113-4122.
24. Phelps CJ, Hurley DL: Pituitary hormones as neurotrophic signals: update on hypothalamic differentiation in genetic models of altered feedback. Proc Soc Exp Biol Med 1999;222:39-58.
25. Weiss S, Shingo T: Effect of growth hormone and IGF-1 on neural stem cells. World intellectual property organisation. USA: Torys LLP, 2003.
26. Shin DH, Lee E, Kim JW, Kwon BS, Jung MK, Jee YH, Kim J, Bae SR, Chang YP: Protective effect of growth hormone on neuronal apoptosis after hypoxia-ischemia in the neonatal rat brain. Neurosci Lett 2004;354:64-68.
27. Scheepens A, Möderscheim TAE, Williams CE, Sirimanne ES, Gluckman PD: Altered growth hormone receptor ligand specificity in the injured rat brain. 4th Forum of European Neurosciences (FENS). Lisbon, Portugal, July 2004. A228-17.
28. Parsons SA, Banks GB, Rowland JA, Coschigano KT, Kopchick JJ, Waters MJ, Noakes PG: Genetic disruption of the growth hormone receptor does not influence motoneuron survival in the developing mouse. Int J Dev Biol 2003;47:41-49.
29. Lai ZN, Emtner M, Roos P, Nyberg F: Characterization of putative growth hormone receptors in human choroid plexus. Brain Res 1991;546:222-226.
30. Fujikawa T, Soya H, Fukuoka H, Alam KS, Yoshizato H, McEwen BS, Nakashima K: A biphasic regulation of receptor mRNA expressions for growth hormone, glucocorticoid and mineralocorticoid in the rat dentate gyrus during acute stress. Brain Res 2000;874:186-193.
31. Kastrup Y, Le Greves M, Nyberg F, Blomqvist A: Distribution of growth hormone receptor mRNA in the brain stem and spinal cord of the rat. Neuroscience 2005;130:419-425.
32. Scheepens A, Sirimanne E, Beilharz E, Breier BH, Waters, MJ, Gluckman PD, Williams CE: Alterations in the neural growth hormone axis following hypoxic-ischemic brain injury. Brain Res Mol Brain Res 1999;68:88-100.
33. Thornwall M, Chhajlani V, Le Greves P, Nyberg F: Detection of growth hormone receptor mRNA in an ovine choroid plexus epithelium cell line. Biochem Biophys Res Commun 1995;217:349-353.
34. Walsh RJ, Slaby FJ, Posner BI: A receptor-mediated mechanism for the transport of prolactin from blood to cerebrospinal fluid. Endocrinology 1987;120:1846-1850.
35. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM: Leptin enters the brain by a saturable system independent of insulin. Peptides 1996;17:305-311.
36. Lynn RB, Cao GY, Considine RV, Hyde TM, Caro JF: Autoradiographic localization of leptin binding in the choroid plexus of ob/ob and db/db mice. Biochem Biophys Res Commun 1996;219:884-889.
37. Linfoot JA, Garcia JF, Wei W, Fink R, Sarin R, Born JL, Lawrence JH: Human growth hormone levels in cerebrospinal fluid. J Clin Endocrinol Metab 1970;31:230-232.
38. Schaub C, Bluet-Pajot MT, Szikla G, Lornet C, Talairach J: Distribution of growth hormone and thyroid-stimulating hormone in cerebrospinal fluid and pathological compartments of the central nervous system. J Neurol Sci 1977;31:123-131.
39. Mayberry HE, Van den Brande JL, Van Wyk JJ, Waddell WJ: Early localization of 125-I-labelled human growth hormone in adrenals and other organs of immature hypophysectomized rats. Endocrinology 1971;88:1309-1317.
40. Belchetz PE, Ridley RM, Baker HF: Studies on the accessibility of prolactin and growth hormone to brain: effect of opiate agonists on hormone levels in serial, simultaneous plasma and cerebrospinal fluid samples in the rhesus monkey. Brain Res 1982;239:310-314.
41. Persson AI, Aberg ND, Oscarsson J, Isaksson OG, Ronnback L, Frick F, Sonesson C, Eriksson PS: Expression of delta opioid receptor mRNA and protein in the rat cerebral cortex and cerebellum is decreased by growth hormone. J Neurosci Res 2003;71:496-503.
42. Lai Z, Roos P, Zhai O, Olsson Y, Fholenhag K, Larsson C, Nyberg F: Age-related reduction of human growth hormone-binding sites in the human brain. Brain Res 1993;621:260-266.
43. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP: Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 1981;67:1361-1369.
44. Schneider HJ, Pagotto U, Stalla GK: Central effects of the somatotropic system. Eur J Endocrinol 2003;149:377-392.
45. Deijen JB, de Boer H, van der Veen EA: Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology 1998;23:45-55.
46. Golgeli A, Tanriverdi F, Suer C, Gokce C, Ozesmi C, Bayram F, Kelestimur F: Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy. Eur J Endocrinol 2004;150:153-159.
47. Oertel H, Schneider HJ, Stalla GK, Holsboer F, Zihl J: The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism. Psychoneuroendocrinology 2004;29:839-850.
48. Noguchi T: Retarded cerebral growth of hormone-deficient mice. Comp Biochem Physiol C 1991;98:239-248.
49. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F: Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 1995;14:717-730.
50. Pelton EW, Grindeland RE, Young E, Bass NH: Effects of immunologically induced growth hormone deficiency on myelinogenesis in developing rat cerebrum. Neurology 1977;27:282-288.
51. Noguchi T, Sugisaki T, Tsukada Y: Postnatal action of growth and thyroid hormones on the retarded cerebral myelinogenesis of Snell dwarf mice (dw). J Neurochem 1982;38:257-263.
52. Noguchi T, Sugiasaki T, Tsukada Y: Microcephalic cerebrum with hypomyelination in the growth hormone-deficient mouse (lit). Neurochem Res 1985;10:1097-1106.
53. Sugisaki T, Beamer WG, Noguchi T: Microcephalic cerebrum with hypomyelination in the pygmy mouse (pg). Int J Dev Neurosci 1992;10:453-458.
54. Noguchi T: Effects of growth hormone on cerebral development: morphological studies. Horm Res 1996;45:5-17.
55. McIlwain DL, Hoke VB, Kopchick JJ, Fuller CR, Lund PK: Differential inhibition of postnatal brain, spinal cord and body growth by a growth hormone antagonist. BMC Neurosci 2004;5:6 (electronic publication).
56. Dey BR, Spence SL, Nissley P, Furlanetto RW: Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. J Biol Chem 1998;273:24095-24101.
57. Ransome MI, Goldshmit Y, Bartlett PF, Waters MJ, Turnley AM: Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness. Eur J Neurosci 2004;19:2069-2079.
58. Vierhapper H, Nowotny P, Waldhausl W: Treatment with growth hormone suppresses cortisol production in man. Metabolism 1998;47:1376-1378.
59. Miller DB, Bartke A, Ocallaghan JP: Increased glial fibrillary acidic protein (GFAP) levels in the brains of transgenic mice expressing the bovine growth hormone (bGH) gene. Exp Gerontol 1995;30:383-400.
60. Bohlooly-Y M, Olsson B, Gritli-Linde A, Brusehed O, Isaksson OG, Ohlsson C, Soderpalm B, Tornell J: Enhanced spontaneous locomotor activity in bovine GH transgenic mice involves peripheral mechanisms. Endocrinology 2001;142:4560-4567.
61. Bohlooly-Y M, Olsson B, Bruder CE, Linden D, Sjogren K, Bjursell M, Egecioglu E, Svensson L, Brodin P, Waterton JC, Isaksson OG, Sundler F, Ahren B, Ohlsson C, Oscarsson J, Tornell J: Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia. Diabetes 2005;54:51-62.
62. Scheepens A, van de Waarenburg M, van den Hove D, Blanco CE: A single course of prenatal betamethasone in the rat alters postnatal brain cell proliferation but not apoptosis. J Physiol 2003;552(Pt 1):163-175.
63. Fuentes-Pardo B, Hernandez-Falcon J, Velazquez PN, Romano MC: Role of corticosterone on the development of passive electrical properties of cultured chick embryo neurons. J Dev Physiol 1990;13:67-73.
64. Antonow-Schlorke I, Schwab M, Li C, Nathanielsz PW: Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain. J Physiol 2003;547:117-123.
65. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, Hsieh WS, Lien YJ: Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 1998;101:E7.
66. Guevara-Aguirre J, Rosenbloom AL, Vaccarello MA, Fielder PJ, de la Vega A, Diamond FB Jr, Rosenfeld RG: Growth hormone receptor deficiency (Laron syndrome): clinical and genetic characteristics. Acta Paediatr Scand Suppl 1991;377:96-103.
67. Laron Z, Galatzer A: Effect of hGH on head circumference and IQ in isolated growth hormone deficiency. Early Hum Dev 1981;5:211-214.
68. Laron Z, Galatzer A: Growth hormone, somatomedin and prolactin - relationship to brain function. Brain Dev 1985;7:559-567.
69. Andronikof-Sanglade A, Fjellestad-Paulsen A, Ricard-Malivoir S, Evain-Brion D: Specific abnormalities in a visual motor psychological test in short children with abnormal growth hormone secretion. Acta Paediatr 1997;86:154-159.
70. Baumann G: Mutations in the growth hormone releasing hormone receptor: a new form of dwarfism in humans. Growth Horm IGF Res 1999;9(suppl B):24-29; discussion 29-30.
71. Bondy CA, Cheng CM: Signaling by insulin-like growth factor 1 in brain. Eur J Pharmacol 2004;490:25-31.
72. Gluckman PD, Grumbach MM, Kaplan SL: The neuroendocrine regulation and function of growth hormone and prolactin in the mammalian fetus. Endocr Rev 1981;2:363-395.
73. Isaksson OGP, Lindahl A, Nilsson A, Isgaard J: Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 1987;8:426-438.
74. Breier BH, Gluckman PD: The regulation of postnatal growth: nutritional influences on endocrine pathways and function of the somatotrophic axis. Livestock Production Science 1991;27:77-94.
75. Underwood LE, Van Wyk JJ: Normal and aberrant growth; in Wilson JD, Foster DW (eds): Williams Textbook of Endocrinology, ed 8. Philadelphia, Saunders, 1992, pp 1079-1138.
76. Baumann G: Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr Rev 1991;12:424-449.
77. Hill DJ, Francis MJ, Milner RD: Action of rat prolactin on plasma somatomedin levels in the rat and on somatomedin release from perfused rat liver. J Endocrinol 1977;75:137-143.
78. Herman A, Bignon C, Daniel N, Grosclaude J, Gertler A, Djiane J: Functional heterodimerization of prolactin and growth hormone receptors by ovine placental lactogen. J Biol Chem 2000;275:6295-6301.
79. Bulow B, Hagmar L, Orbaek P, Osterberg K, Erfurth EM: High incidence of mental disorders, reduced mental well-being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease. Clin Endocrinol (Oxf) 2002;56:183-193.
80. Rosilio M, Blum WF, Edwards DJ, Shavrikova EP, Valle D, Lamberts SW, Erfurth EM, Webb SM, Ross RJ, Chihara K, Henrich G, Herschbach P, Attanasio AF: Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H). J Clin Endocrinol Metab 2004;89:1684-1693.
81. Lundgren EM, Cnattingius S, Jonsson B, Tuvemo T: Birth characteristics and different dimensions of intellectual performance in young males: a nationwide population-based study. Acta Paediatr 2003;92:1138-1143.
82. O'Keeffe MJ, O'Callaghan M, Williams GM, Najman JM, Bor W: Learning, cognitive, and attentional problems in adolescents born small for gestational age. Pediatrics 2003;112:301-307.
83. Hutton JL, Pharoah PO, Cooke RW, Stevenson RC: Differential effects of preterm birth and small gestational age on cognitive and motor development. Arch Dis Child Fetal Neonatal Ed 1997;76:F75-F81.
84. van Pareren YK, Duivenvoorden HJ, Slijper FS, Koot HM, Hokken-Koelega AC: Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age. J Clin Endocrinol Metab 2004;89:5295-5302.